Literature DB >> 3065349

An improved method for the detection of HIV antigen in the blood of carriers.

S Kageyama1, O Yamada, S S Mohammad, S Hama, N Hattori, M Asanaka, E Nakayama, T Matsumoto, F Higuchi, T Kawatani.   

Abstract

The measurement of HIV antigen levels in sera or plasma of HIV-infected individuals is critical for determining the existence of antigen or infectious virus before seroconversion and for prognosis. Pretreatment of sera or plasma of HIV carriers by heating at 70 degrees C for 10 min at an acidic pH enabled us to estimate antigens efficiently in immune complexes. This procedure will also be useful in determining antigen levels in HIV carriers more precisely.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3065349     DOI： 10.1016/0166-0934(88)90095-x

Source DB:  PubMed          Journal:  J Virol Methods        ISSN： 0166-0934            Impact factor:   2.014


  9 in total

1.  Comparison of the frequencies and levels of human immunodeficiency virus type 1 markers in specimens from chronically infected human T-lymphocyte cultures and from patients.

Authors:  D J Witt; C C Ginocchio; X P Wang; M K Kaufman
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Evaluation of two enzyme immunoassays for detection of human immunodeficiency virus antigen in African and European sera.

Authors:  G Vercauteren; P Piot; M Vandenbruaene; G van der Groen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

Review 3.  Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee.

Authors:  S Hammer; C Crumpacker; R D'Aquila; B Jackson; J Lathey; D Livnat; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

4.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

5.  A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.

Authors:  J A Beatty; B J Willett; E A Gault; O Jarrett
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Clinical utility of an enhanced human immunodeficiency virus type 1 p24 antigen capture assay.

Authors:  M B Vasudevachari; N P Salzman; D R Woll; C Mast; K W Uffelman; G Toedter; D Hoefheinz; J A Metcalf; H C Lane
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

7.  Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection.

Authors:  D R Henrard; S Wu; J Phillips; D Wiesner; J Phair
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

8.  Stability of free and complexed human immunodeficiency virus type 1 antigen at 4 degrees C and at room temperature.

Authors:  B P Griffith; R B Garner; T M Chacko
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Comparison of an amplified enzyme-linked immunosorbent assay with procedures based on molecular biology for assessing human immunodeficiency virus type 1 viral load.

Authors:  P L Goldschmidt; A Devillechabrolle; Z Ait-Arkoub; J T Aubin
Journal:  Clin Diagn Lab Immunol       Date:  1998-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.